Actively Recruiting
Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes
Led by University of Vermont · Updated on 2026-02-03
30
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Why Is This Research Study Being Conducted? * The study wants to find out why people with a type of blood cancer called myelodysplastic syndromes (MDS) are more likely to have heart problems like heart disease and stroke. * Researchers also want to see if certain proteins related to inflammation in the body can help predict these heart issues in MDS patients. * By understanding this better, researchers hope to find new ways to detect and manage heart disease risks in people with MDS
CONDITIONS
Official Title
Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Confirmed diagnosis of myelodysplastic syndromes by bone marrow biopsy using 2022 WHO classification
- Eastern Cooperative Oncology Group (ECOG) performance status of 3 or less
- Expected survival of at least 6 months
- Ability to provide consent
You will not qualify if you...
- Diagnosis of MDS with excess blasts 2 as initial diagnosis according to 2022 WHO criteria
- Planned hematopoietic stem cell transplantation within 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Vermont
Burlington, Vermont, United States, 05495-2038
Actively Recruiting
Research Team
D
Diego Adrianzen Herrera, MD
CONTACT
N
Neil A Zakai, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here